Gene therapy restores hearing in 16-month-old Everett

Everett Tynes, a 16-month-old with genetic deafness, received a new gene therapy called Otarmeni at Boston Children’s Hospital to restore his hearing. The treatment, approved in April and provided free of charge by Regeneron, involves delivering a working copy of his defective gene directly into his inner ear through surgery. While it is too early to determine the full success, Everett shows signs of increased awareness and responsiveness, offering hope for natural hearing restoration through genetic therapy.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل